Leukemia and sepsis are different, they are not the same thing

Share This Post

People who know nothing about leukemia are the most frightened. They will definitely mix sepsis and leukemia. They think this is a disease. In fact, these are two different diseases. Leukemia is more serious than sepsis. It is called blood cancer. Leukemia can only be matched by bone marrow, but sepsis is a condition caused by external wounds, and it must not be confused, so that correct and favorable judgment can be made when the disease is discovered.

Septicemia is mostly caused by trauma. Severe trauma has not been completely treated. Bacteria invade the blood and multiply in it, producing serious diseases caused by endotoxin and exotoxin. The main clinical manifestations are chills, high fever, various rashes, hepatosplenomegaly, toxic hepatitis and myocarditis, abdominal distension, vomiting, blood in the stool, headache, coma, etc. If there are multiple abscesses in the whole body, it is called sepsis. Severe patients can find white blood cells increased by routine examination (can also be reduced in severe cases), and more than two blood cultures can cultivate the same bacteria.

Leukemia, commonly referred to as “blood cancer,” is a malignant disease of the hematopoietic system caused by viral infection or exposure to radiation, chemical poisons, and so on. The main clinical manifestations are fever, nosebleeds, gum bleeding, gastrointestinal bleeding and so on. In addition, there is bone and joint pain, headache, liver and spleen and lymphadenopathy, testicular swelling and pain. Finding leukemia cells by bone marrow aspiration is the basis for diagnosis.

In theory, leukemia is more serious than sepsis, because the patient’s hematopoietic function is affected, and once the wound appears, it is very difficult to heal. Septicemia can usually be cured after selecting the appropriate antibiotic treatment, and leukemia can be cured after a long period of treatment, and if it is not paid attention to in later care, it is easy to relapse.

For leukemia, in addition to bone marrow matching, there is also a type of cellular immunotherapy. From the body, patients with immune cells that fight against foreign bodies such as cancer cells and viruses are taken out of the blood, cultured in the laboratory to increase the number, and return to After the body, the patient’s immune power is restored again, and the treatment method of attacking the tumor is now. The standard treatment is to kill the cancer cells from the external force, and the normal cells will also be killed or injured. The cancer immune cell treatment is to use the patient’s own Of immune cells attack cancer cells, will not attack normal cells, have no side effects, and can also be used in conjunction with the three standard therapies. Recent studies have shown that immune cell therapy can improve the effectiveness of the three standard treatments, improve patient survival, and improve The patient’s quality of life.

It can be seen that leukemia and sepsis are two completely different diseases, one directly threatens life, and the other is indeed highly likely to be cured, but no matter what kind of impact on the body can not be underestimated, patients Only by actively cooperating with the treatment can your body recover slowly and gradually.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient A case report
CAR T-Cell therapy

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient : A case report

Claudin18.2-targeted CAR-T cell therapy has shown remarkable potential in treating advanced pancreatic cancer, as highlighted in a recent case report. This innovative approach led to complete remission in a patient with advanced disease, underscoring the promise of targeted immunotherapy. By leveraging the specific expression of Claudin18.2 on cancer cells, this therapy offers a precision-based treatment, heralding a new era in pancreatic cancer management with significant clinical implications.

What is the treatment after BCMA CAR T failed in RR multiple myeloma cases
CAR T-Cell therapy

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

For people with relapsed or refractory multiple myeloma, BCMA CAR T-cell therapy might not work. Other treatments, such as bispecific antibodies, other CAR T-cell therapies that target different antigens, and combination regimens with immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, can still be used. OriCAR-017 is another immunotherapy that is under trial and is expected to be launched soon. Clinical trials offer experimental treatments, providing access to novel therapies. Tailored approaches based on patient-specific factors and emerging research are crucial for improving outcomes in this challenging scenario.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy